Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers

Cancer Research

Volumn 62, Issue 8, 2002, Pages 2370-2377

  Belinsky, Steven A ^a   Palmisano, William A ^a   Gilliland, Frank D ^b   Crooks, Lida A ^c   Divine, Kevin K ^a   Winters, Sally A ^a   Grimes, Marcie J ^a   Harms, Heidi J ^a   Tellez, Carmen S ^a   Smith, Tammy M ^d   Moots, Pam P ^d   Lechner, John F ^a,e   Stidley, Christine A ^d   Crowell, Richard E ^c,d  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^e BAYER CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN KINASE; PROTEIN P16; RAS PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRONCHUS MUCOSA; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPATHOLOGY; DNA METHYLATION; EARLY DIAGNOSIS; EPITHELIUM CELL; FEMALE; GENE FREQUENCY; GENE INACTIVATION; GENE ISOLATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; SMOKING; SMOKING CESSATION; SPUTUM ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; BRONCHI; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CASE-CONTROL STUDIES; CELLS, CULTURED; CHROMOSOMES, HUMAN, PAIR 9; DNA METHYLATION; EPITHELIAL CELLS; FEMALE; GENES, P16; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PROMOTER REGIONS (GENETICS); SMOKING; SPUTUM; TUMOR SUPPRESSOR PROTEINS;

EID: 0037089460     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Cancer statistics, 1998
2. INK4ais an early event in lung cancer and a potential biomarker for early diagnosis
3. Predicting lung cancer by detecting aberrant promoter methylation in sputum
4. Alterations in DNA methylation: A fundamental aspect of neoplasia
5. Baylin a novel PCR assay for methylation status of CpG islands
6. 6-methylguaine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia
7. Development of carcinoma of the lung as reflected in exfoliated cells
8. Detection of oncogene mutations in sputum precedes diagnosis of cancer
9. Microsatellite alterations as clonal markers for the detection of human cancer
10. The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer
11. Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy
12. N-(4-Hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium
13. Field cancerization in oral stratified squamous epithelium. Clinical implications of multicentric origin
14. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumors, are detectable in preinvasive lesions of the bronchus
15. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung
16. p53 protein accumulates frequently in early bronchial neoplasia
17. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions
18. Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients
19. Molecular damage in the bronchial epithelium of current and former smokers
20. Clonal genetic alterations in the lungs of current and former smokers
21. Detection of trisomy 7 in nonmalignant bronchial epithelium from lung cancer patients and individuals at risk for lung cancer
22. Frequency of trisomy 20 in nonmalignant bronchial epithelium from lung cancer patients and cancer-free former uranium miners and smokers
23. Hypermethylation of the death-associated protein (D. A. P) kinase promoter and aggressiveness in stage I non-small cell lung cancer
24. Aberrant promoter methylation of multiple genes in non-small cell lung cancer
25. Epigenetic inactivation of a Ras association domain family protein from the lung tumor suppressor locus 3p21.3
26. Epidemiology standardization project
27. Changes in bronchial epithelium in relation to cigarette smoking, 1955-1960 versus 1970-1977
28. Hot spots of chromium accumulation at bifurcations of chromate workers' bronchi
29. Confluence-induced alterations in CpG island methylation in cultured normal human fibroblasts
30. De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyl-transferase
31. Cytogenetic analysis of 63 non-small cell lung carcinomas: Recurrent chromosome alterations amid frequent and widespread genomic upheaval
32. Loss of heterozygosity at 9p23 defines a novel locus in non-small cell lung cancer
33. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers
34. Detection of hyperdiploidy and chromosome breakage in interphase human lymphocytes following exposure to the benzene metabolites hydroquinone using multicolor fluorescence in situ hybridization with DNA probes
35. Detection of chromosome instability of tissue fields at risk: In situ hybridization
36. Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer
37. Smoking, smoking cessation, and lung cancer in the UK since 1950: Combination of national statistics with two case-control studies
38. Inactivation of p16 in human mammary epithelial cells by CpG island methylation
39. ogrowth arrest
40. 2+/calmodulindependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity
41. P-kinase participates in TNF-α and Fas-induced apoptosis and its function requires the death domain
42. ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation
43. Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus
44. Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy, and p53 expression
45. Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma
46. Bronchial epithelium in former smokers
47. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin
48. Inhibition of DNA cytosine methyltransferase by chemopreventive selenium compounds, determined by an improved assay for cytosine methyltransferase and DNA cytosine methylation